Literature DB >> 25142477

Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature.

Peter Dorfmüller1, Sven Günther2, Maria-Rosa Ghigna3, Vincent Thomas de Montpréville4, David Boulate5, Jean-François Paul6, Xavier Jaïs7, Benoit Decante5, Gérald Simonneau7, Philippe Dartevelle8, Marc Humbert7, Elie Fadel9, Olaf Mercier9.   

Abstract

Limited numbers of operated patients with chronic thromboembolic pulmonary hypertension (CTEPH) are refractory to pulmonary endarterectomy (PEA) and experience persistent pulmonary hypertension (PH). We retrospectively assessed lung histology available from nine patients with persistent PH (ineffective PEA (inPEA) group) and from eight patients transplanted for distal CTEPH inaccessible by PEA (noPEA group). Microscopically observed peculiarities were compared with the histology of a recently developed CTEPH model in piglets. Pre-interventional clinical/haemodynamic data and medical history of patients from the inPEA and noPEA groups were collected and analysed. Conspicuous remodelling of small pulmonary arteries/arterioles, septal veins and pre-septal venules, including focal capillary haemangiomatosis, as well as pronounced hypertrophy and enlargement of bronchial systemic vessels, were the predominant pattern in histology from both groups. Most findings were reproduced in our porcine CTEPH model. Ink injection experiments unmasked abundant venular involvement in so-called small vessel or microvascular disease, as well as post-capillary bronchopulmonary shunting in human and experimental CTEPH. Microvascular disease is partly due to post-capillary remodelling in human and experimental CTEPH and appears to be related to bronchial-to-pulmonary venous shunting. Further studies are needed to clinically assess the functional importance of this finding. ©ERS 2014.

Entities:  

Mesh:

Year:  2014        PMID: 25142477     DOI: 10.1183/09031936.00169113

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  41 in total

1.  Poor Subpleural Perfusion Predicts Failure After Balloon Pulmonary Angioplasty for Nonoperable Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Yu Taniguchi; Philippe Brenot; Xavier Jais; Carlos Garcia; Jason Weatherald; Olivier Planche; Elie Fadel; Marc Humbert; Gérald Simonneau
Journal:  Chest       Date:  2018-05-03       Impact factor: 9.410

2.  Endothelial Hypoxia-Inducible Factor-2α Is Required for the Maintenance of Airway Microvasculature.

Authors:  Xinguo Jiang; Wen Tian; Allen B Tu; Shravani Pasupneti; Eric Shuffle; Petra Dahms; Patrick Zhang; Haoliang Cai; Thanh T Dinh; Bo Liu; Corey Cain; Amato J Giaccia; Eugene C Butcher; M Celeste Simon; Gregg L Semenza; Mark R Nicolls
Journal:  Circulation       Date:  2019-01-22       Impact factor: 29.690

3.  Life expectancy after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: a Swedish single-center study.

Authors:  Janica Kallonen; Natalie Glaser; Fredrik Bredin; Matthias Corbascio; Ulrik Sartipy
Journal:  Pulm Circ       Date:  2020-04-14       Impact factor: 3.017

Review 4.  Chronic thromboembolic pulmonary hypertension: detection, medical and surgical treatment approach, and current outcomes.

Authors:  David S Poch; William R Auger
Journal:  Heart Fail Rev       Date:  2016-05       Impact factor: 4.214

Review 5.  Epidemiology and Pathophysiology of Chronic Thromboembolic Pulmonary Hypertension: Risk Factors and Mechanisms.

Authors:  Sarah Medrek; Zeenat Safdar
Journal:  Methodist Debakey Cardiovasc J       Date:  2016 Oct-Dec

Review 6.  Diagnosis and Management of Pulmonary Hypertension in Patients With CKD.

Authors:  Carl P Walther; Vijay Nambi; Nicola A Hanania; Sankar D Navaneethan
Journal:  Am J Kidney Dis       Date:  2020-03-19       Impact factor: 8.860

Review 7.  Current concepts in the pathogenesis of chronic thromboembolic pulmonary hypertension.

Authors:  Daniel T Matthews; Anna R Hemnes
Journal:  Pulm Circ       Date:  2016-06       Impact factor: 3.017

8.  Hot topics in the mechanisms of pulmonary arterial hypertension disease: cancer-like pathobiology, the role of the adventitia, systemic involvement, and right ventricular failure.

Authors:  Edda Spiekerkoetter; Elena A Goncharova; Christophe Guignabert; Kurt Stenmark; Grazyna Kwapiszewska; Marlene Rabinovitch; Norbert Voelkel; Harm J Bogaard; Brian Graham; Soni S Pullamsetti; Wolfgang M Kuebler
Journal:  Pulm Circ       Date:  2019-11-20       Impact factor: 3.017

9.  The role of β-catenin in pulmonary artery endothelial-mesenchymal transformation in rats with chronic thromboembolic pulmonary hypertension.

Authors:  Meie Zeng; Shimou Chen; Hongli Li; Zhigui Huang; Dawen Wu; Yunchang Pan; Chaosheng Deng
Journal:  J Thromb Thrombolysis       Date:  2021-03-02       Impact factor: 2.300

10.  Platelet-derived growth factor-BB induces pulmonary venous smooth muscle cells proliferation by upregulating calcium sensing receptor under hypoxic conditions.

Authors:  Rongmin Liu; Juan Xu; Yongliang Jiang; Wei Hong; Shaoxing Li; Zhenli Fu; Weitao Cao; Bing Li; Pixin Ran; Gongyong Peng
Journal:  Cytotechnology       Date:  2021-02-27       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.